Monday, August 25th, 2025
Stock Profile: LSTA
LSTA Logo

Lisata Therapeutics, Inc. (LSTA)

Market: NASD | Currency: USD

Address: 110 Allen Road

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Show more




📈 Lisata Therapeutics, Inc. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2022 - $0.066667 - 2022-09-15 - Stock split
Total Amount for 2022: $0.066667
2016 - $0.100000 - 2016-07-28 - Stock split
Total Amount for 2016: $0.100000


📅 Earnings & EPS History for Lisata Therapeutics, Inc.


DateReported EPS
2025-11-11 (estimated upcoming)-
2025-08-07-0.54
2025-05-08-0.55
2025-02-27-0.55
2024-11-12-0.59
2024-08-12-0.61
2024-05-09-0.65
2024-02-29-0.66
2023-11-02-0.65
2023-08-14-0.5
2023-05-09-0.77
2023-03-30-0.76
2022-11-10-1.47
2022-08-04-1.65
2022-05-05-1.05
2022-03-22-1.65
2021-11-04-1.8
2021-08-05-1.5
2021-05-06-2.85
2021-02-25-4.2
2020-11-05-4.35
2020-08-137.5
2020-05-08-5.7
2020-03-05-7.05
2019-11-06-7.05




📰 Related News & Research


No related articles found for "lisata therapeutics".